Biotech · Private company
InSilico Medicine Hong Kong Limited
Track this companyFree. Adds InSilico Medicine Hong Kong Limited to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- INS018_055Phase 2 · Idiopathic Pulmonary Fibrosis (IPF)ClinicalTrials.gov · fetched Nov 12, 2026
- ISM3412Phase 2 · Locally Advanced/Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- ISM6331Phase 2 · Malignant MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started Apr 25, 2025ClinicalTrials.gov NCT06414460 · fetched Nov 12, 2026
- Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Dec 27, 2024ClinicalTrials.gov NCT06566079 · fetched Nov 12, 2026
- Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary FibrosisPHASE2 · RECRUITING · started Feb 8, 2024ClinicalTrials.gov NCT05975983 · fetched Nov 12, 2026